GB1531278A - 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof - Google Patents

9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof

Info

Publication number
GB1531278A
GB1531278A GB51318/75A GB5131875A GB1531278A GB 1531278 A GB1531278 A GB 1531278A GB 51318/75 A GB51318/75 A GB 51318/75A GB 5131875 A GB5131875 A GB 5131875A GB 1531278 A GB1531278 A GB 1531278A
Authority
GB
United Kingdom
Prior art keywords
methanoanthracene
dihydro
production
oxide derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB51318/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Priority to GB51318/75A priority Critical patent/GB1531278A/en
Priority to CA267,280A priority patent/CA1079282A/en
Priority to JP51148259A priority patent/JPS6054302B2/ja
Priority to DE19762656078 priority patent/DE2656078A1/de
Priority to FR7637505A priority patent/FR2335207A1/fr
Priority to NL7613937A priority patent/NL7613937A/xx
Priority to AU20593/76A priority patent/AU504589B2/en
Priority to US05/750,630 priority patent/US4153629A/en
Publication of GB1531278A publication Critical patent/GB1531278A/en
Priority to US06/007,711 priority patent/US4216231A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB51318/75A 1975-12-15 1975-12-15 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof Expired GB1531278A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB51318/75A GB1531278A (en) 1975-12-15 1975-12-15 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
CA267,280A CA1079282A (en) 1975-12-15 1976-12-07 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and production thereof
JP51148259A JPS6054302B2 (ja) 1975-12-15 1976-12-09 ９，１０‐ジヒドロ‐９，１０‐メタノアントラセン・ｎ‐オキシド誘導体およびその製法
DE19762656078 DE2656078A1 (de) 1975-12-15 1976-12-10 9,10-dihydro-9,10-methanoanthracenderivate und ihre herstellung
FR7637505A FR2335207A1 (fr) 1975-12-15 1976-12-13 Derives de n-oxyde de 9,10-dihydro-9,10-methanoanthracene et leur utilisation, notamment comme tranquillisants et comme agents anti-epilepsie
NL7613937A NL7613937A (nl) 1975-12-15 1976-12-15 Derivaten van 9,10-dihydro-9,10-methaanantraceen n-oxyde.
AU20593/76A AU504589B2 (en) 1975-12-15 1976-12-15 N-oxides of 9, 10-dehydro-9, 10-methanoanthracene "aminoalkyl derivatives
US05/750,630 US4153629A (en) 1975-12-15 1976-12-15 9,10-Dihydro-9,10-methanoanthracene N-oxide
US06/007,711 US4216231A (en) 1975-12-15 1979-01-30 9,10-Dihydro-9,10-methanoanthracene N-oxide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB51318/75A GB1531278A (en) 1975-12-15 1975-12-15 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof

Publications (1)

Publication Number Publication Date
GB1531278A true GB1531278A (en) 1978-11-08

Family

ID=10459524

Family Applications (1)

Application Number Title Priority Date Filing Date
GB51318/75A Expired GB1531278A (en) 1975-12-15 1975-12-15 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof

Country Status (8)

Country Link
US (2) US4153629A (enExample)
JP (1) JPS6054302B2 (enExample)
AU (1) AU504589B2 (enExample)
CA (1) CA1079282A (enExample)
DE (1) DE2656078A1 (enExample)
FR (1) FR2335207A1 (enExample)
GB (1) GB1531278A (enExample)
NL (1) NL7613937A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531278A (en) * 1975-12-15 1978-11-08 Shionogi & Co 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
CA2014201A1 (en) * 1989-04-26 1990-10-26 Albemarle Corporation Solid non-hygroscopic trialkylamine oxides
KR960008230B1 (ko) * 1989-10-17 1996-06-21 윌리엄 쥐.씨먼 중추신경계의 산화적 손상에 관련된 질병들을 억제하기 위한 조성물들
US20050107366A1 (en) * 1991-06-18 2005-05-19 Carney John M. Spin trapping pharmaceutical compositions and methods for use thereof
US6002001A (en) * 1991-06-18 1999-12-14 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5512575A (en) * 1991-08-15 1996-04-30 Zeneca Limited Methanoanthraceneyl methyl piperidinyl compounds
GB9216297D0 (en) * 1991-08-15 1992-09-16 Ici Plc Therapeutic agents
GB9117639D0 (en) * 1991-08-15 1991-10-02 Ici Plc Therapeutic compounds
GB9216298D0 (en) * 1991-08-15 1992-09-16 Ici Plc Piperidine derivatives
US6693064B2 (en) 1996-04-16 2004-02-17 Unichema Chemie B.V. Hydraulic fluids
US5900227A (en) * 1996-06-17 1999-05-04 Oklahoma Medical Research Foundation Multicyclic nitrone spin trapping compositions
KR20080065704A (ko) 2005-11-09 2008-07-14 콤비네이토릭스, 인코포레이티드 의학적 이상의 치료 방법들, 조성물들, 및 키트들

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB618034A (en) * 1946-10-16 1949-02-15 Geigy Ag J R Manufacture of basically substituted 9:10-dihydroanthracene derivatives, and their salts and amino-oxides
NL127069C (enExample) * 1961-10-10
GB991651A (en) * 1963-02-20 1965-05-12 Dumex Ltd As Dibenzocycloheptadiene derivatives
US3579582A (en) * 1967-02-16 1971-05-18 Universal Oil Prod Co Hydroxy and/or hydrocarbyloxy and amino substituted tetrahydronaphthalenes
US3493616A (en) * 1967-02-27 1970-02-03 Universal Oil Prod Co Hydroxy and/or hydrocarbyloxy and amino-alkano-tetrahydronaphthalenes
US3952017A (en) * 1968-05-03 1976-04-20 Hoffmann-La Roche Inc. Tricyclic compounds
US3622630A (en) * 1968-07-03 1971-11-23 Smith Kline French Lab 10-aminoalkyl-9,10-dihydroanthracenes
GB1531278A (en) * 1975-12-15 1978-11-08 Shionogi & Co 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof

Also Published As

Publication number Publication date
CA1079282A (en) 1980-06-10
JPS6054302B2 (ja) 1985-11-29
JPS5273853A (en) 1977-06-21
FR2335207A1 (fr) 1977-07-15
US4216231A (en) 1980-08-05
AU2059376A (en) 1978-06-22
FR2335207B1 (enExample) 1979-06-22
AU504589B2 (en) 1979-10-18
NL7613937A (nl) 1977-06-17
US4153629A (en) 1979-05-08
DE2656078A1 (de) 1977-06-23

Similar Documents

Publication Publication Date Title
GB1552911A (en) 1,4 dihydropyridine derivatives and the preparation thereof
NZ181619A (en) 1-aminoalkoxy-4-substituted-1 2, 3, 4-tetrahydroiso-quinolines
GB1531278A (en) 9,10-dihydro-9,10-methanoanthracene n-oxide derivatives and the production thereof
GB1557687A (en) 4,6di o aminoglycosyl 1,3 diaminocyclitol derivatives and their pretaration
GB1520958A (en) 11-deoxy-16-aryl - 17,18,19,20 - tetranorprostaglandins
IL49476A0 (en) 2-amino-2-alkylthio-1-nitroethylenes and their production
ZA764847B (en) 1,2-benzisoxazole derivatives and production thereof
ZA774704B (en) 1,5 disubstituted-2-pyrrolidones and processes for their production
IL48624A0 (en) 2,3-dihydroergolines
JPS5265280A (en) Benzoxadinones and their production
AU1214076A (en) 2,3-dihalogen-alkanoyl-ureas
PH14168A (en) 2,4-pyrrolidinediones
GB1557694A (en) 2,9 dichlorquinacridone
JPS51113898A (en) 88aminootheophiline derivative * production and application thereof
NZ182127A (en) 6 ,17 -dihydroxy-1 -loweralkoxycarbonyl-3-oxo-17 -pregn-4-ene-21-carboxylic acid -lactones
GB1554021A (en) 4,5-didehydroprostaglandins
GB1483330A (en) 2,5-dimethoxy-4-chloroaniline
IL50436A (en) 4-halomethyl-or hydroxymethyl-2-pyrrolidinone and 4-aminomethyl-tetrahydrofuran-2-one derivatives and their production
GB1554925A (en) 2,3-methyl-eneprostaglandins
ZA766301B (en) Substituted 2,1,3-benzothiadiazine
JPS5225774A (en) 2*1*33benzothiazole derivatives and production thereof
AU1483576A (en) 16,16-dimethyl-prostaglandins
AU1724576A (en) 2,4-diamino-5-benzylpyrimidines
JPS5257162A (en) Azetidinee22ones and production thereof
IL48365A0 (en) 10,11-dihydro-3-carboxycyproheptadine and its n-oxide

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee